Avoro Capital Advisors LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 104 filers reported holding XENON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$167,384,000
-11.3%
4,900,0000.0%2.61%
+2.0%
Q2 2023$188,650,000
+7.6%
4,900,0000.0%2.56%
-1.6%
Q1 2023$175,371,000
-9.2%
4,900,0000.0%2.60%
-9.9%
Q4 2022$193,207,000
+9.2%
4,900,0000.0%2.89%
-11.7%
Q3 2022$176,890,000
+18.7%
4,900,0000.0%3.27%
+11.0%
Q2 2022$149,058,000
-2.2%
4,900,000
-1.7%
2.94%
+5.9%
Q1 2022$152,391,000
-2.1%
4,985,0000.0%2.78%
+5.0%
Q4 2021$155,731,000
+179.2%
4,985,000
+36.6%
2.65%
+202.5%
Q3 2021$55,772,000
-17.9%
3,650,0000.0%0.88%
-25.9%
Q2 2021$67,963,000
+4.0%
3,650,0000.0%1.18%
+4.8%
Q1 2021$65,335,000
+51.7%
3,650,000
+30.4%
1.13%
+52.0%
Q4 2020$43,064,000
+38.9%
2,800,0000.0%0.74%
+68.6%
Q3 2020$30,996,000
-11.7%
2,800,0000.0%0.44%
-36.6%
Q2 2020$35,112,000
+11.7%
2,800,000
+1.0%
0.69%
-34.6%
Q1 2020$31,434,000
-0.1%
2,772,000
+15.5%
1.06%
+14.8%
Q4 2019$31,464,000
+45.5%
2,400,0000.0%0.92%
+2.4%
Q3 2019$21,624,000
-8.6%
2,400,0000.0%0.90%
+10.3%
Q2 2019$23,664,000
-3.0%
2,400,0000.0%0.82%
-22.4%
Q1 2019$24,384,000
+61.0%
2,400,0000.0%1.05%
+16.5%
Q4 2018$15,144,000
-51.5%
2,400,000
+1.4%
0.90%
-36.9%
Q3 2018$31,247,000
+182.5%
2,367,218
+96.9%
1.44%
+236.9%
Q2 2018$11,059,0001,202,1180.43%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 850,000$15,215,0003.58%
ACUTA CAPITAL PARTNERS, LLC 412,500$7,384,0002.66%
BVF INC/IL 3,481,778$62,324,0002.34%
Soleus Capital Management, L.P. 708,117$12,675,0002.28%
COMMODORE CAPITAL LP 301,392$5,395,0002.15%
DAFNA Capital Management LLC 406,535$7,277,0001.73%
Parkman Healthcare Partners LLC 374,395$6,702,0001.56%
Avoro Capital Advisors LLC 3,650,000$65,335,0001.13%
KNOTT DAVID M 144,101$2,579,0001.10%
Orbimed Advisors 2,497,917$44,713,0000.42%
View complete list of XENON PHARMACEUTICALS INC shareholders